The invention provides two human reticulocalbin isoforms designated individually as RCN gamma and RCN delta and collectively as RCN, and polynucleotides which identify and encode RCN. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of RCN.
